icon-close
fren

Also in this section

2025-2029 Research Funding Competition

SCN’s national research funding competition supports world-class, translational, regenerative medicine research, across the research continuum, to facilitate health, social and economic benefits for Canadians.

Research Funding Opportunities – Call for Full Applications is Now Closed

Applicants will be notified of decisions by mid-April.

The Letter of Intent (LOI) submission period for SCN’s current funding competition closed on September 24, 2024, with the deadline for full applications on December 3, 2024.

If you missed this opportunity, we encourage you to stay connected with SCN for future funding calls. Please check back regularly or subscribe to our newsletter for updates on upcoming funding opportunities.

The Stem Cell Network has launched the first of two national research funding competitions for the 2025-2029 funding cycle. The Round 1 competition opened on Tuesday, September 3, 2024, and offers both 24- and 36-month awards. Six regenerative medicine research programs are available that focus on innovation, clinical translation, policy and societal impact and commercialization.

New this year, SCN is proud to collaborate with three organizations to offer joint-funding award opportunities. These organizations are:

Watch the webinar recording to learn more about SCN’s new research funding competition launched on September 3, 2024.

Important Dates:

  • LOI submissions opened on Tuesday, September 3, 2024.
  • LOI submissions closed Tuesday, September 24, 2024, at 11:59 p.m. PT. An LOI submission was mandatory to be considered for the full application phase.
  • Full application submissions open for eligible LOI submitters on Tuesday, October 1, 2024.
  • Full application submission deadline is Tuesday, December 3, 2024, at 5:00 p.m. ET (2:00 p.m. PT).

The six programs are:

Accelerating Clinical Translation Awards
SCN will provide up to $650,000 to support multi-disciplinary research that is moving towards the clinic within five years; or is addressing a key research question associated with an ongoing clinical trial.

Joint-Funded Awards valued at $780K are also available in collaboration with Azrieli Foundation or Breakthrough T1D for this program – consult the Joint-Funding Program Guidelines for more details.

Clinical Trial Awards
SCN will provide up to $1,100,000 to support early-stage clinical trial projects with high translational potential.

Joint-Funded Awards valued at $1,320,000 are also available in collaboration with Azrieli Foundation or Breakthrough T1D for this program – consult the Joint-Funding Program Guidelines for more details.

Early Career Researcher Jump Start Awards
SCN will provide up to $350,000 for early career researchers (within the first five years of an initial academic appointment) to develop a research program with a regenerative medicine focus.

Joint-Funded Awards valued at $420K are also available in collaboration with Azrieli Foundation for this program – consult the Joint-Funding Program Guidelines for more details.

Fueling Biotechnology Partnerships Awards
SCN will provide up to $430,000 to support academic partnerships with emerging Canadian regenerative medicine biotechnology companies to bring innovative technologies or therapies to the clinic or market.

Joint-Funded Awards of $500K and $516K are also available in collaboration with CQDM or Breakthrough T1D for this program – consult the Joint-Funding Program Guidelines for more details.

Impact Awards
SCN will provide up to $270,000 to support proof-of-principle experiments, including novel therapeutic or technical approach development that will drive regenerative medicine therapies forward.

Joint-Funded Awards valued at $324K are also available in collaboration with Azrieli Foundation or Breakthrough T1D for this program – consult the Joint-Funding Program Guidelines for more details.

Impact Awards: Ethical, Legal and Social Implications (ELSI) & Health Economics (HE) Stream
SCN will provide up to $215,000 to support studies focused on the ethical, legal, social, and health economic implications of regenerative medicine.

Joint-Funded Awards valued at $258K are also available in collaboration with Azrieli Foundation or Breakthrough T1D for this program – consult the Joint-Funding Program Guidelines for more details.



Resources:

Guidelines for Joint Funding Award Opportunities

Questions:
LOI and full application-related questions should be addressed to SCN’s Research team at researchSCN@stemcellnetwork.ca.

To view previous funding competition results, visit our Funded research database page.